PPLPHARMA.NSE Piramal Pharma Limited

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Piramal Pharma Ltd. market cap is 220.75B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Piramal Pharma Ltd. 52 week high is 172.25 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Piramal Pharma Ltd. 52 week low is 87.50 as of July 26, 2024.

Piramal Pharma Ltd. stock price today is 166.10.

Piramal Pharma Ltd. stock price yesterday was 165.50.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Piramal Pharma Ltd.’s P/E ratio is 2217.18.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Piramal Pharma Ltd. P/B ratio is 2.7844.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Piramal Pharma Ltd.'s EBITDA is 17.67.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Piramal Pharma Ltd. 50-day moving average is 153.52.

Piramal Pharma Ltd. has 7,933 employees.